WCLC highlights savolitinib combination potential
Data presented at the World Conference on Lung Cancer (WCLC) on combination approaches to treat resistant EGFR-driven non-small cell lung cancer...
88 Views
WCLC highlights savolitinib combination potential
Data presented at the World Conference on Lung Cancer (WCLC) on combination approaches to treat resistant EGFR-driven non-small cell lung cancer...
40 Views
ASCO data set up fruquintinib for China launch
At ASCO, Hutchison China MediTech (HCM) presented detailed Phase III trial results for one of its leading assets, fruquintinib (third-line...
176 Views
ASCO data set up fruquintinib for China launch
At ASCO, Hutchison China MediTech (HCM) presented detailed Phase III trial results for one of its leading assets, fruquintinib (third-line...
120 Views
Future stars are aligning
Despite a strong run over the last 12 months, our increased valuation of $2.7bn suggests the market overlooks HCM’s full R&D potential....
103 Views